Aspirin, the painkiller-turned-heart protector being used by millions of people, is now under scrutiny. Even after 100 years of use, doctors across the world have no clue how it exactly works in protecting against heart attack and stroke and what would be its right dosage.
India, therefore, will soon be part of a trial that is looking to better understand aspirin's effect on the body and optimal dosing. Medanta Medicity, which joined hands with Duke Medicine, North Carolina, to create the Medanta Duke Research Institute, will be the trial site to unravel the mystery behind aspirin.
Source:http://timesofindia.indiatimes.com/india/How-safe-is-an-aspirin-Trial-to-tell/articleshow/7448805.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment